MycroDose Therapeutics: Funding, Investors & Team (Aug 2026)
Mycrodose Therapeutics is a US-Based pharmaceutical company specialized in the development of advanced drug delivery (ADD) systems utilizing psychedelic compounds to treat mental health and cognitive degenerative diseases. The company is in the parallel development of two of its four core technologies; a psilocybin transdermal delivery system, Ketamine oral mucosa delivery system.
MycroDose Therapeutics has raised $100k across 1 funding round on record, the most recent a Seed of $100k announced in Sep 2021.
That round is below the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
MycroDose Therapeutics Company Profile and Key Stats
Latest funding round on record: Sep 2021.
MycroDose Therapeutics Funding Rounds
MycroDose Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
MycroDose Therapeutics Funding Compared to Other Health Care Startups
MycroDose Therapeutics' latest round of $100k is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like MycroDose Therapeutics in Health Care and San Diego
Companies Similar to MycroDose Therapeutics
https://metriport.com
There are too many reasons why Healthcare is unaffordable in the U.S, but one of the largest is waste. Up to…
Serif Health provides healthcare price intelligence and contract management solution.
Switchboard Health provides virtual care solutions to payers, health systems, employers, and at-risk…
Astek Diagnostics has designed a system that helps doctors choose the right antibiotics for patients…
TECLens is developing a crosslinking technology that can effectively address vision problems in both healthy…
Healthcare Shares operates as a crowdfunding portal for the transformative medical innovations of the future.
Gradient Health collaborates with medical data providers worldwide to assemble diseases and conditions for AI…
Kalivir designs safe and potent oncolytic product candidates across multiple tumor types. Kalivir’s…
Happy Health is a mission-driven technology company committed to transforming mental health awareness through…
Leal Therapeutics creates new treatments for patients.
Teal Health is on a mission to empower women when it comes to their health – starting with at-home cervical…
MycroDose Therapeutics Funding FAQs
What does MycroDose Therapeutics do?
Mycrodose Therapeutics is a US-Based pharmaceutical company specialized in the development of advanced drug delivery (ADD) systems utilizing psychedelic compounds to treat mental health and cognitive degenerative diseases. The company is in the parallel development of two of its four core technologies; a psilocybin transdermal delivery system, Ketamine oral mucosa delivery system.
How much funding has MycroDose Therapeutics raised?
MycroDose Therapeutics has raised $100k across 1 round on record. The most recent is a Seed of $100k announced in Sep 2021.
When did MycroDose Therapeutics last raise funding?
MycroDose Therapeutics' most recent funding round on record is a Seed of $100k, announced in Sep 2021.
Who is the CEO of MycroDose Therapeutics?
Chad Conner is listed as CEO at MycroDose Therapeutics.
Where is MycroDose Therapeutics headquartered?
MycroDose Therapeutics is based in San Diego, California, United States.
How many employees does MycroDose Therapeutics have?
MycroDose Therapeutics is in the 1-10 employee band.
How does MycroDose Therapeutics' funding compare to other Health Care startups?
MycroDose Therapeutics' latest round of $100k is below the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's MycroDose Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for MycroDose Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.